The goal of this study is to identify the mechanisms activated by Oct4 and Sox2 reprogramming transcription factors that drive glioma-propagating stem cells and determine their potential as targets for developing novel anti-cancer therapeutics. The gene discussed is SOX2; the disease is central nervous system cancer.